Centers | ||
|
|
|
EU-OPENSCREEN | Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | FDA Oncology Center of Excellence Project Catalyst |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
Partnerships |
Events |
Jobs |
Novartis and University of Pennsylvania form Alliance in Oncology AreaUniversity of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus and will be responsible to develop T Cell... View all Sanofi and Weill Cornell Medical College to Discover New Drus to Treat TuberculosisSanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of... View all CEOdevelopment of peptide therapeutics to metastatic cancer View all |
No EVENTS for listing |
No Job Posts |
